We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
A web-based location experience platform for businesses to market their content for their target audience by users visiting physical locations to view digital content. Landmrk's service is currently used by travel, entertainment and retail industries and allows businesses to provide 'rewards' when customers reach the location. Revenue is primarily generated from marketing agencies and businesses licensing the platform on a monthly, quartely or annual basis.
days to go: Expired investment: £519,364
Growth Capital Ventures (GCV) is a Financial Conduct Authority (FCA) approved fintech company. GCV's mission is to back the game changers, innovators and value creators. It is operating at three different levels namely, G-Ventures, a specialist software development division; Quva, a private investor network; and G- Labs, an innovation lab. The company aims to provide investors with access to well researched alternative investment opportunities that are selected for their potential to deliver better returns than traditional mainstream investment products. GCV has structured property transactions worth £14.7 million, has 5000+ everyday investors, and seen 500+ jobs created by portfolio companies. GCV will use the investment to grow its business across different verticals. 
days to go: Expired investment: £1,295,410
Jupiter Diagnostics provide a patent-protected portable reader and test card to provide reliable and cost-effective blood results. Each test card has the ability to measure multiple tests from a prick of blood from the finger and can deliver laboratory-quality results in just ten minutes.
days to go: Expired investment: £2,005,050
TheCarCrowd is a Passion Asset Investment (PAI) platform that intends to address the lack of investment options for the 8 million UK millennials by allowing them to take a real equity stake in a classic car and benefit from the potential appreciation. The company argues that classic cars appreciated 194% over 10 years up to Q4 2019 as per expert reports. TheCarCrowd points out that its portal allows interested investors to buy shares in cars from just £20 and unlock the benefits of potential appreciation. The company asserts that its business idea has found traction amidst users with over 620 investors registering on the portal since the company's launch in November 2020. TheCarCrowd will use 12% of the investment for Public Relations (PR), 48% for marketing, and 40% for working capital.

Pitch Rated

46%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £379,108
Span Health is a digital care platform that aims to help people avoid lifestyle-induced diseases, symptoms, medication, and complications. The company has helped more than 10,000 people to live a better and longer life. Span Health's easy-to-use mobile application allows patients to chat with clinicians, order blood tests at home, book video consultations, and see results in the application itself. Moreover, in 2019, the company agreed on a National Health Service (NHS) pilot test for 100 patients in collaboration with the National Institute of Health Research in North West London. Span Health will use the investment to provide employees with blood tests to screen for health risk factors and recover from detected illness safely and sustainably, improve its platform data insights, prediction and machine learning to better structure the clinician's processes, and further reduce its operational costs.

Pitch Rated

78%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £134,892
Billon have created a technology that enables zero cost global payments by the use of a simple mobile app. Billon's mobile app allows you to instantly pay for the rest of an article from the Guardian or even donate to your favourite Youtubers with a few clicks of a button. 
days to go: Expired investment: £1,406,667
Findr aims to automate the creation of business partnerships by providing easy access to hyper-targeted opportunities in minutes. The company asserts that its platform allows any business, regardless of its size, to sign up, post its partnership requirements, and explore opportunities for free. The company's portal allows users to request a 1-hour 'Discovery' call with a potential partner when the said user spots a relevant opportunity. Findr argues that it has made 'Discovery' for free for the first few months to build its user base. The company has onboarded 140 business users ranging from early-stage to global brands such as Mastercard, Uber and Visa since November 2020. Findr has featured in Forbes for helping businesses navigate COVID-19. The company will use the investment to develop two new price plans – Unlimited and Enterprise, introduce new platform features, hire a machine learning expert, and undertake digital activity to grow its user base.

Pitch Rated

51%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £396,288
Wombat is an investment platform that encourages millenials in the UK, Europe and beyond to invest in some of the world’s best-known brands for as little as £10. Their mission is to empower the generation of millenials to manage, save and grow money by breaking down barriers to traditional investing. The Wombat app was launched in the summer of 2019, and the company has already acquired more than 5,000 customers. Moreover, the company was nominated as Best Newcomer for the Robo Investing Awards and received positive press coverage. With the proceeds, Wombat is planning to build a strong customer base, fulfil growth strategy with a significant increase in marketing, product development, and to educate customers about investing.

Pitch Rated

53%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £435,717
Antev Limited (Antev) is a clinical-stage biopharmaceutical firm which focuses on the evolution of a drug used for prostate cancer, Teverelix TFA. The company is working on growing its copyright protection and is currently developing phase IIb clinical plans for prostate cancer. Antev is a pre-revenue company that aims at increasing its shareholder value by progressing the development of teverelix TFA towards registration whose approval is anticipated from 2023 onwards. The proceeds will be used for production, IP development, working capital and to develop a phase IIb repeat dosing clinical trial in prostate cancer.
days to go: Expired investment: Withheld
Carnot is developing hydrogen engines with key components manufactured from ceramics able to withstand fuel combustion temperatures, eliminating the need for cooling systems and doubling the efficiencies of modern engines. The company argues that modern engines waste on average one-third of fuel energy to cool systems that stop metallic components from melting. Carnot claims that its engines eliminate this waste doubling efficiency, halve fuel costs and CO2 and achieve net-zero operation by operating on biofuels and hydrogen benefiting the long haul transport, marine and primary off-grid power markets. Carnot has raised over £600,000 including a pre-seed round in 2020 for £357,000 at a pre-money valuation of £2 million, a £300,000 Innovate UK grant and another £300,000 Eureka Eurostar’s grant. Carnot has a 5-year, 3-phase exit strategy and will begin licensing its IP at the end of 2023 at which point it will begin generating revenue. It will eventually look for acquisition from one of its manufacturing partners in 2025 after demonstrating industry acceptance of its technology.
days to go: Expired investment: £262,500
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph